Acorah Software Products - Accounts Production 19.2.450 false true 31 December 2024 1 January 2024 false 1 January 2025 31 December 2025 31 December 2025 14842793 Dr P Finigan Mr J E Powell Uk Vein Clinic Group Limited true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14842793 2024-12-31 14842793 2025-12-31 14842793 2025-01-01 2025-12-31 14842793 frs-core:CurrentFinancialInstruments 2025-12-31 14842793 frs-core:Non-currentFinancialInstruments 2025-12-31 14842793 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-01-01 2025-12-31 14842793 frs-core:OtherResidualIntangibleAssets 2025-12-31 14842793 frs-core:OtherResidualIntangibleAssets 2025-01-01 2025-12-31 14842793 frs-core:OtherResidualIntangibleAssets 2024-12-31 14842793 frs-core:PlantMachinery 2025-12-31 14842793 frs-core:PlantMachinery 2025-01-01 2025-12-31 14842793 frs-core:PlantMachinery 2024-12-31 14842793 frs-core:ShareCapital 2025-12-31 14842793 frs-core:RetainedEarningsAccumulatedLosses 2025-12-31 14842793 frs-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 14842793 frs-bus:FilletedAccounts 2025-01-01 2025-12-31 14842793 frs-bus:SmallEntities 2025-01-01 2025-12-31 14842793 frs-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 14842793 frs-bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 14842793 1 2025-01-01 2025-12-31 14842793 frs-bus:Director1 2025-01-01 2025-12-31 14842793 frs-bus:Director2 2025-01-01 2025-12-31 14842793 frs-countries:EnglandWales 2025-01-01 2025-12-31 14842793 2023-12-31 14842793 2024-12-31 14842793 2024-01-01 2024-12-31 14842793 frs-core:CurrentFinancialInstruments 2024-12-31 14842793 frs-core:Non-currentFinancialInstruments 2024-12-31 14842793 frs-core:ShareCapital 2024-12-31 14842793 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31
Registered number: 14842793
UK Vein Clinic (Surrey) Limited
Financial Statements
For The Year Ended 31 December 2025
Fairman Harris
1 Landor Road
London
SW9 9RX
UK Vein Clinic (Surrey) Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—5

Page 1
UK Vein Clinic (Surrey) Limited
Balance Sheet
As At 31 December 2025
Balance Sheet
Registered number: 14842793

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Intangible Assets | 4 |  | - |  | 24,722
Tangible Assets | 5 |  | - |  | 11,685
|  |  | - |  | 36,407
CURRENT ASSETS
Debtors | 7 | - |  | 1,766 |
|  | - |  | 1,766 |
Creditors: Amounts Falling Due Within One Year | 8 | (3,840 ) |  | (2,400 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | (3,840 ) |  | (634 )
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | (3,840 ) |  | 35,773
Creditors: Amounts Falling Due After More Than One Year | 9 |  | - |  | (191,365 )
NET LIABILITIES |  |  | (3,840 ) |  | (155,592 )
CAPITAL AND RESERVES
Called up share capital | 10 |  | 1 |  | 1
Profit and Loss Account |  |  | (3,841 ) |  | (155,593 )
SHAREHOLDERS' FUNDS |  |  | (3,840) |  | (155,592)

Page 1
Page 2
UK Vein Clinic (Surrey) Limited
Balance Sheet (continued)
As At 31 December 2025
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Mr J E Powell Director
2 July 2026

The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
UK Vein Clinic (Surrey) Limited
Notes to the Financial Statements
For The Year Ended 31 December 2025
Notes to the Financial Statements
1. General Information
UK Vein Clinic (Surrey) Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14842793 . The registered office is Lower Ground Floor, 150 Harley Street, London, W1G 7LQ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Intangible Fixed Assets and Amortisation - Other Intangible
Other intangible assets are set up cost. It is amortised to profit and loss account over its estimated economic life of 10 years.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant & Machinery | 20% Straight Line Method

2.5. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: NIL)
- -
4. Intangible Assets

| Other
--- | ---
| £
Cost
As at 1 January 2025 | 28,843
Disposals | (28,843 )
As at 31 December 2025 | -

...CONTINUED
Page 3
Page 4
UK Vein Clinic (Surrey) Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025

Amortisation
As at 1 January 2025 | 4,121
Provided during the period | 2,884
Disposals | (7,005 )
As at 31 December 2025 | -
Net Book Value
As at 31 December 2025 | -
As at 1 January 2025 | 24,722

5. Tangible Assets

| Plant & Machinery
--- | ---
| £
Cost
As at 1 January 2025 | 17,100
Disposals | (17,100 )
As at 31 December 2025 | -
Depreciation
As at 1 January 2025 | 5,415
Provided during the period | 3,420
Disposals | (8,835 )
As at 31 December 2025 | -
Net Book Value
As at 31 December 2025 | -
As at 1 January 2025 | 11,685

6. Stocks

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £

7. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Prepayments and accrued income | - |  | 1,766

8. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Trade creditors | 2,400 |  | -
Accruals and deferred income | 1,440 |  | 2,400
| 3,840 |  | 2,400

Page 4
Page 5
UK Vein Clinic (Surrey) Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
9. Creditors: Amounts Falling Due After More Than One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Amounts owed to associates | - |  | 191,365

10. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 1 |  | 1

11. Related Party Transactions
Uk Vein Clinic Ltd - Intercompany balance: £ Nil (2024 Cr £103,217)
Uk Vein Clinic Group Limited balance - holding company: £Nil (2024 Cr £88,149)
12. Ultimate Controlling Party
The company's ultimate controlling party is Uk Vein Clinic Group Limited by virtue of its ownership of 100% of the issued share capital in the company.
Page 5